About Us | Contact

Dr. Robert Barnes Colvin Investigator

Immunopathology NPI1922098458
Update NPI

Open Payments

Note

The following payment details are based on a national transparency program known as the Sunshine Act that collects and publishes information about financial relationships between the health care industry (i.e. drug and device manufactures) and providers. These relationships may involve payment to providers for things such as research, speaking engagment, travel, gifts etc. Not all of these payment involve monetary compensations and may include batering of drugs or devices.

Total Payment Worth

$88,331.46
from 21 payments in the last 6 years

Total Cash or Cash Equivalent

$88,119.00
from 18 payments in the last 6 years

Total In-kind Items & Services

$212.46
from 3 payments in the last 6 years

Nature of Payments

Last 6 Years
Chart will render here...

Yearly Breakdown

Chart will render here...

Payment Details

Date Payment Type Form of Payment Item/Service Payment Amount
03/05/2019 General (Non-Research) In-kind items and services Food and Beverage $117.49 Details
Payment from Alexion Pharmaceuticals, Inc.
Payment Record ID 695595089
03/18/2019 General (Non-Research) In-kind items and services Food and Beverage $63.60 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 685664151
06/25/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $2185.00 Details
Payment from Shire North American Group Inc
Payment Record ID 637805951
05/21/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $5890.00 Details
Payment from Shire North American Group Inc
Payment Record ID 637805949
03/19/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $4180.00 Details
Payment from Shire North American Group Inc
Payment Record ID 637805947
02/12/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $9975.00 Details
Payment from Shire North American Group Inc
Payment Record ID 637805945
02/12/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $8569.00 Details
Payment from Shire North American Group Inc
Payment Record ID 637805943
01/08/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $7125.00 Details
Payment from Shire North American Group Inc
Payment Record ID 637805941
01/08/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $8170.00 Details
Payment from Shire North American Group Inc
Payment Record ID 637805939
08/28/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $3800.00 Details
Payment from Shire North American Group Inc
Payment Record ID 565980227
10/09/2018 Research Cash or cash equivalent Drug $7915.00 Details
Payment from Shire North American Group Inc
Paymment Research Study A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CINRYZE C1 ESTERASE INHIBITOR HUMAN FOR THE TREATMENT OF ACUTE ANTIBODY-MEDIATED REJECTION IN KIDNEY TRANSPLANT PATIENTS
Payment Record ID 565227002
10/09/2018 Research Cash or cash equivalent Drug $1110.00 Details
Payment from Shire North American Group Inc
Paymment Research Study A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CINRYZE C1 ESTERASE INHIBITOR HUMAN FOR THE TREATMENT OF ACUTE ANTIBODY-MEDIATED REJECTION IN KIDNEY TRANSPLANT PATIENTS
Payment Record ID 565226997
09/25/2018 Research Cash or cash equivalent Drug $9500.00 Details
Payment from Shire North American Group Inc
Paymment Research Study A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CINRYZE C1 ESTERASE INHIBITOR HUMAN FOR THE TREATMENT OF ACUTE ANTIBODY-MEDIATED REJECTION IN KIDNEY TRANSPLANT PATIENTS
Payment Record ID 565226995
04/19/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $8020.00 Details
Payment from Shire North American Group Inc
Payment Record ID 466982213
03/05/2017 General (Non-Research) In-kind items and services Food and Beverage $31.37 Details
Payment from Alexion Pharmaceuticals, Inc.
Payment Record ID 463107079
02/08/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $3960.00 Details
Payment from Alexion Pharmaceuticals, Inc.
Payment Record ID 463106947
02/24/2016 General (Non-Research) Cash or cash equivalent Consulting Fee $2470.00 Details
Payment from Shire North American Group Inc
Payment Record ID 394185218
01/01/2016 General (Non-Research) Cash or cash equivalent Consulting Fee $350.00 Details
Payment from GENZYME CORPORATION
Payment Record ID 393564076
01/05/2016 Research Cash or cash equivalent Drug $700.00 Details
Payment from SANOFI US SERVICES INC.
Paymment Research Study AGAL06207 Central
Payment Record ID 392672508
01/05/2016 Research Cash or cash equivalent Drug $1050.00 Details
Payment from SANOFI US SERVICES INC.
Paymment Research Study AGAL06207 Central
Payment Record ID 392672466
01/27/2016 General (Non-Research) Cash or cash equivalent Consulting Fee $3150.00 Details
Payment from Alexion Pharmaceuticals, Inc.
Payment Record ID 392490204
;